Bringing Light to the Blind: Innovative Cell Therapy for Retinal Degenerative Diseases

🔍Over 250 million people worldwide suffer from blindness caused by retinal degenerative diseases.

💡Injel Therapeutics is a company that is focused on developing innovative cell therapy and tissue engineering solutions for treating retinal degenerative diseases.

🧪Their technology is gene agnostic and has shown tremendous safety and efficacy in treating various diseases, including retinitis pigmentosa and dry age-related macular degeneration.

🤝Injel Therapeutics welcomes anyone interested in learning more about their work to talk to them and join their journey to bring back light to patients.

🌟Their mission is to provide treatment and hope to patients who currently have no cure or treatment options for their retinal degenerative diseases.

How many people worldwide are affected by retinal degenerative diseases?

—Over 250 million people worldwide are affected by retinal degenerative diseases, leading to various degrees of blindness.

What does Injel Therapeutics specialize in?

—Injel Therapeutics specializes in developing innovative cell therapy and tissue engineering solutions for the treatment of retinal degenerative diseases.

What diseases can their technology treat?

—Their technology can be used to treat various diseases, including retinitis pigmentosa and dry age-related macular degeneration.

What is the mission of Injel Therapeutics?

—The mission of Injel Therapeutics is to bring back light to patients suffering from retinal degenerative diseases by providing safe and effective treatment options.

How can I learn more about Injel Therapeutics?

—If you're interested in learning more about Injel Therapeutics, you can talk to them directly to get more information.

00:00Pierre, co-founder and CEO of Injel Therapeutics, talks about the global issue of blindness caused by retinal degenerative diseases.

00:14Many patients suffering from retinal degenerative diseases have no treatment options or cure, and they fear permanent blindness.

00:31Injel Therapeutics aims to bring back light to these patients through innovative cell therapy and tissue engineering solutions.

00:44Their technology is gene agnostic and has demonstrated safety and efficacy in treating diseases like retinitis pigmentosa and dry age-related macular degeneration.

00:51Injel Therapeutics welcomes those interested in their work to talk to them and join their mission to bring back light to patients.